---
title: Personalized Experimental Design
videoId: gN-6DfhCguA
---

From: [[causalpython]] <br/> 

Personalized experimental design, often referred to as N-of-1 trials, involves a study of a single person or subject. These trials are randomized, typically using a crossover design, to understand individual responses to interventions over time <a class="yt-timestamp" data-t="00:00:00">[00:00:00]</a> <a class="yt-timestamp" data-t="00:06:06">[00:06:06]</a> <a class="yt-timestamp" data-t="02:35:38">[02:35:38]</a>. The core purpose of these designs is to generate personalized models, meaning their findings are primarily meant to generalize to the individual being studied, rather than a broader population <a class="yt-timestamp" data-t="00:12:00">[00:12:00]</a> <a class="yt-timestamp" data-t="02:09:58">[02:09:58]</a>.

Dr. Eric Daza, a principal clinical data scientist, is a key figure in this field, having been inspired by [[causal_inference_in_single_subject_studies | N-of-1 trials]] due to his work in pharma, a course on [[causal_inference_in_single_subject_studies | causal inference]] by Mark Vanderland, and personal experience with a loved one suffering from irritable bowel syndrome (IBS) <a class="yt-timestamp" data-t="03:27:29">[03:27:29]</a> <a class="yt-timestamp" data-t="03:31:04">[03:31:04]</a>.

## Defining N-of-1 Trials
An N-of-1 trial is a randomized study of one person <a class="yt-timestamp" data-t="00:00:00">[00:00:00]</a> <a class="yt-timestamp" data-t="02:35:38">[02:35:38]</a>. It functions as a crossover design, where an individual might alternate between conditions, such as drinking coffee or not, and observe the impact on an outcome like sleep <a class="yt-timestamp" data-t="02:44:03">[02:44:03]</a>. These are also known as time series designs <a class="yt-timestamp" data-t="03:16:16">[03:16:16]</a> or switchback experiments in finance <a class="yt-timestamp" data-t="15:17:20">[15:17:20]</a>.

## Key Concepts and Challenges

### Serial Interference
In N-of-1 trials, the concept of interference, typically between different individuals in a study, transforms into "serial interference" <a class="yt-timestamp" data-t="05:57:00">[05:57:00]</a>. This means a treatment given at one time point affects the potential outcomes of the *same person* at a future time point <a class="yt-timestamp" data-t="06:46:00">[06:46:00]</a>. Notably, interference cannot occur backward in time <a class="yt-timestamp" data-t="07:09:00">[07:09:00]</a>.

### Challenges in Time Series Settings
Main challenges in single-subject time series designs include:
*   **Carryover effects:** When the effect of a treatment persists into subsequent periods <a class="yt-timestamp" data-t="07:31:00">[07:31:00]</a>.
*   **Autocorrelation:** Outcomes at one time point being naturally correlated with outcomes at previous time points (e.g., migraines on consecutive days) <a class="yt-timestamp" data-t="07:54:00">[07:54:00]</a>.
*   **Exogenous factors:** External variables not affected by treatment or outcome (e.g., weather) but influencing outcomes <a class="yt-timestamp" data-t="08:14:00">[08:14:00]</a>.
*   **Non-stationarity:** The underlying distribution of the outcome changing over time <a class="yt-timestamp" data-t="00:40:51">[00:40:51]</a>. While classic [[clinical_trial_design_and_optimization | N-of-1 trials]] aim for stationarity through controlled designs (e.g., waiting for drug washout, short study durations), real-world applications face this challenge <a class="yt-timestamp" data-t="00:41:01">[00:41:01]</a>. Strategies like segmenting data or stationarization (e.g., taking first differences) can be used, but these can change the study question <a class="yt-timestamp" data-t="00:43:59">[00:43:59]</a>.

## Benefits and Application
N-of-1 designs are particularly useful when outcomes have highly [[heterogeneous_treatment_effect_estimation | heterogeneous triggers]] across individuals, or when the same trigger can have opposite effects on different people <a class="yt-timestamp" data-t="09:34:00">[09:34:00]</a> <a class="yt-timestamp" data-t="09:42:00">[09:42:00]</a>. For example, coffee might worsen migraines for one person but prevent them for another <a class="yt-timestamp" data-t="09:42:00">[09:42:00]</a>. In such cases, a traditional randomized control trial (RCT) might show no average treatment effect due to cancellation <a class="yt-timestamp" data-t="09:59:00">[09:59:00]</a>.

These trials enable the estimation of [[individual_treatment_effects | individual treatment effects]] for recurring conditions <a class="yt-timestamp" data-t="38:15:00">[38:15:00]</a>. However, they are not suitable for irreversible events like death, as they only occur once <a class="yt-timestamp" data-t="39:15:00">[39:15:00]</a>.

### Statistical Machinery
The primary difference in statistical analysis for N-of-1 trials compared to group-based studies is the shift to a time series setting <a class="yt-timestamp" data-t="12:35:00">[12:35:00]</a>. The standard independence assumption between participants is replaced by assumptions like stationarity, and accounting for lagged outcomes and autocorrelation becomes crucial <a class="yt-timestamp" data-t="12:46:00">[12:46:46]</a>.

A key estimate in this context is the **Average Period Treatment Effect (APTE)** <a class="yt-timestamp" data-t="10:54:00">[10:54:00]</a>. Similar to the average treatment effect (ATE) in group studies, APTE compares outcomes under different treatment levels across distinct time periods for the same individual <a class="yt-timestamp" data-t="11:46:00">[11:46:00]</a>.

## Designing and Running an N-of-1 Study

### Generalizability
N-of-1 trials are designed for personalization and are not typically meant to generalize to broader populations <a class="yt-timestamp" data-t="02:09:58">[02:09:58]</a>. Their purpose is to identify patterns specific to the individual <a class="yt-timestamp" data-t="02:11:00">[02:11:00]</a>. While secondary goals might involve borrowing information across people using methods like mixed effects models, N-of-1 specifically allows for models that can differ significantly per person <a class="yt-timestamp" data-t="02:24:00">[02:24:00]</a>.

### Practical Advice
For individuals or clinicians interested in designing an N-of-1 trial:
1.  **Define the Study Question:** Clearly articulate the specific question you want to answer. This is the "root of really good science" <a class="yt-timestamp" data-t="01:14:00">[01:14:00]</a> <a class="yt-timestamp" data-t="02:38:00">[02:38:00]</a> <a class="yt-timestamp" data-t="02:58:00">[02:58:00]</a>.
2.  **Specify Variables and Measurement:** Determine what variables to collect, how to measure them (e.g., passive sensors like Fitbits, daily diaries, lab values), and ensure feasibility <a class="yt-timestamp" data-t="02:15:00">[02:15:00]</a> <a class="yt-timestamp" data-t="02:22:00">[02:22:00]</a>.
3.  **Prioritize Design:** As Donald Rubin famously stated, "Design trumps analysis" <a class="yt-timestamp" data-t="01:01:00">[01:01:00]</a> <a class="yt-timestamp" data-t="02:13:15">[02:13:15]</a> <a class="yt-timestamp" data-t="00:59:00">[00:59:00]</a>. A well-designed study is crucial for trustworthy and reliable conclusions <a class="yt-timestamp" data-t="00:42:00">[00:42:00]</a>.

## Software Ecosystem
Several software tools can assist with N-of-1 trials:
*   **Tummy trials:** An early app for people with irritable bowel syndrome <a class="yt-timestamp" data-t="02:17:00">[02:17:00]</a>.
*   **Migraine Buddy:** Primarily a self-tracking app <a class="yt-timestamp" data-t="02:39:00">[02:39:00]</a>.
*   **Study Me:** A newer package for self-experimentation platforms <a class="yt-timestamp" data-t="02:50:00">[02:50:00]</a>.

## Causal Identification and Frameworks
While the potential outcomes framework is commonly used, directed acyclic graphs (DAGs) from Pearl's framework are highly useful for [[causal_inference_in_single_subject_studies | N-of-1 trials]] <a class="yt-timestamp" data-t="01:57:00">[01:57:00]</a> <a class="yt-timestamp" data-t="01:18:00">[01:18:00]</a>. DAGs provide a visual way to represent causal relationships, especially in time series, by showing arrows from the past to the present <a class="yt-timestamp" data-t="01:13:00">[01:13:00]</a>. This helps in understanding identifiability and constructing appropriate models <a class="yt-timestamp" data-t="01:42:00">[01:42:00]</a>.

## Future Directions and Resources
The field of N-of-1 trials is evolving and connecting with other areas:
*   **N-of-1 Collaborative Network:** An Australian-based group that popularizes the design and implementation of N-of-1 trials, offering consulting services <a class="yt-timestamp" data-t="01:17:00">[01:17:00]</a> <a class="yt-timestamp" data-t="01:45:00">[01:45:00]</a>.
*   **Stats of One:** A newsletter focusing on statistical methods, data collection, and software related to N-of-1 trials and single-case designs, bridging literature from psychology, education, time series, and econometrics <a class="yt-timestamp" data-t="01:40:00">[01:40:00]</a> <a class="yt-timestamp" data-t="01:49:00">[01:49:00]</a>.
*   **Functional Data Analysis:** Explores how entire curves or patterns of data (e.g., step counts or blood glucose over a day) differ under various conditions, rather than just averages <a class="yt-timestamp" data-t="01:50:00">[01:50:00]</a> <a class="yt-timestamp" data-t="01:59:00">[01:59:00]</a>.
*   **Control Theory and System Identification:** A promising area connecting [[causal_inference_in_single_subject_studies | causal inference]] with engineering techniques to optimize and stabilize human behavior or physiological states <a class="yt-timestamp" data-t="01:07:00">[01:07:00]</a> <a class="yt-timestamp" data-t="01:57:00">[01:57:00]</a>. This has implications for understanding reliable world models in agentic systems <a class="yt-timestamp" data-t="01:57:00">[01:57:00]</a>.